Provided by Tiger Trade Technology Pte. Ltd.

Cardiff Oncology, Inc.

1.34
+0.03002.29%
Pre-market: 1.33-0.0136-1.01%05:13 EDT
Volume:3.17M
Turnover:4.46M
Market Cap:104.08M
PE:-2.27
High:1.51
Open:1.42
Low:1.31
Close:1.31
52wk High:3.31
52wk Low:0.7566
Shares:77.67M
Float Shares:75.24M
Volume Ratio:3.32
T/O Rate:4.21%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.5914
EPS(LYR):-0.6863
ROE:-94.08%
ROA:-46.73%
PB:3.92
PE(LYR):-1.95

Loading ...

Cardiff Oncology Shares Rise After Upgrade From HC Wainwright

MT Newswires Live
·
14 hours ago

Cardiff Oncology Price Target Announced at $9.00/Share by HC Wainwright & Co.

Dow Jones
·
Yesterday

HC Wainwright Upgrades Cardiff Oncology to Buy From Neutral, Price Target is $9

MT Newswires Live
·
Yesterday

Cardiff Oncology, Inc. : H.c. Wainwright Raises to Buy from Neutral

THOMSON REUTERS
·
Yesterday

Cardiff Oncology upgraded to Buy from Neutral at H.C. Wainwright

TIPRANKS
·
Yesterday

U.S. Research Roundup-Eli Lilly, McDonald's, Welltower

Reuters
·
Yesterday

Analysts Offer Insights on Healthcare Companies: Addus Homecare (ADUS) and Cardiff Oncology (CRDF)

TIPRANKS
·
Sep 14

Cardiff Oncology - no Admission of Liability or Monetary Payment in Cardiff-Nerviano Settlement - SEC Filing

THOMSON REUTERS
·
Sep 14

Cardiff Oncology, Nerviano Settle Onvansertib Rights Lawsuit, Seek Dismissal with Prejudice

Reuters
·
Sep 14

Cardiff Oncology, - Co and Nms Agree to Full Mutual Release of All Claims in Litigation

THOMSON REUTERS
·
Sep 14

Cardiff Oncology and Nerviano Medical Sciences Amend Their 2017 Exclusive License Agreement

THOMSON REUTERS
·
Sep 14

Cardiff Oncology to Present at RAS-Targeted Drug Development Summit

Reuters
·
Sep 02

Cardiff Oncology Announces Special Shareholder Meeting

Reuters
·
Aug 27

Cardiff Oncology Announces Special Shareholder Meeting

Reuters
·
Aug 15

Replimune Q1 Net Loss Narrows as Expenses Decline

Reuters
·
Aug 14

Elicio Therapeutics Q2 Net Loss Narrows as R&D Expenses Fall

Reuters
·
Aug 14

PDS Biotechnology Q2 Net Loss Widens Slightly as Operating Costs Fall

Reuters
·
Aug 13

Pyxis Oncology Q2 Loss Widens on Increased Administrative Costs

Reuters
·
Aug 13

William Blair Downgrades Cardiff Oncology to Market Perform From Outperform

MT Newswires Live
·
Aug 12

Cardiff Oncology, Inc. : William Blair Cuts to Market Perform Rating

THOMSON REUTERS
·
Aug 12